BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
DRD2
,
Coagulation
,
Influenza
,
Embryo
,
Laser capture microdissection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cellular response to leukemia inhibitory factor
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Kidney cortex
Ovary
Thalamus
Midbrain
Hypothalamus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Rhinitis
Alpha-1-antitrypsin deficiency
Legionella infection
Perforation of tympanic membrane
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Lif protein, mouse
niguldipine
CGP 60474
A 443654
flavopiridol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PCDH11X
PPP2R2C
NEUROG1
NCL
POLH
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Embryonic stem cell gene expression profiles after induction of Ca(2+)-activated potassium channels
Expression data from mouse ES cells and various differentiated cell types
Microarray profiling analysis in Jmj-Fl/Fl and Jmj-null embryonic stem cells
Retinoic acid (RA) induction time-course during embryonic stem cell differentiation
Embryonic stem cells treated with vitamin C or retinoic acid
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for cellular response to leukemia inhibitory factor
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspet…
A Study of Ficlatuzumab With HiDAC and HiDAC Alone in Adults With Relapsed or Refractory Acute Myelo…
VALIDATION OF A PREDICTIVE MODEL OF RESPONSE TO ROMIPLOSTIM IN PATIENTS WITH IPSS LOW OR INTERMEDIAT…
Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ